← Percision · Blog

What Is the Single Highest-ROI Move This Quarter for Healthcare Providers?

The highest-ROI move for most healthcare providers this quarter is not a new service line or capital project — it's closing the revenue and throughput leaks you already have: denied claims recovery, reducing patient no-shows, or fixing prior-authorization delays. These moves need little capital, pay back inside a quarter, and free capacity for everything else. To find your specific answer, score your candidate moves with the RICE framework rather than defaulting to the loudest priority in the room.

Why "highest-ROI move" is a scoring problem, not an opinion

Healthcare providers rarely lack ideas. Between physician requests, payer pressure, patient-experience complaints, and staffing gaps, the backlog of "we should really fix that" is endless. The problem is prioritization: everything feels urgent, and the initiatives with executive sponsors win — not the ones with the best return.

Resource allocation under constraint is exactly what the RICE framework is built for. RICE scores each candidate move on four dimensions:

The formula: (Reach × Impact × Confidence) ÷ Effort = RICE score. Rank your candidates by score. The highest score is your quarter's move.

The discipline matters more than the arithmetic. RICE forces you to separate "high impact but enormous effort" (a new EHR module) from "modest impact but trivial effort and instant payback" (auto-reminders for high-no-show clinics).

A concrete RICE walkthrough for a healthcare provider

Say a mid-sized multi-specialty group is debating four Q3 moves. Here's how you'd score them — using your own data, not benchmarks.

Candidate A: Automated claim-denial rework queue

Candidate B: SMS/portal appointment reminders to cut no-shows

Candidate C: New telehealth behavioral-health line

Candidate D: Prior-authorization automation for imaging

Run the numbers and the pattern that usually emerges: B and A score highest because their effort is low and their confidence is high, even though C has the biggest headline impact. That's the point of RICE — it protects you from expensive, uncertain bets when a cheap, certain win is sitting in your backlog.

What "good" looks like: every candidate scored with a real data source behind Reach and Impact; Confidence honestly reflecting uncertainty (not padded to justify a favorite project); Effort estimated with the teams who'll do the work; and a written record so you can revisit assumptions next quarter.

Where Percision fits — and where it doesn't

I work with Percision, so treat this as one option, not the only one. Percision is a strategic intelligence platform that runs your business context through structured reasoning steps to produce board-ready analysis in minutes rather than weeks.

For a RICE-based prioritization, Percision helps in three ways:

  1. Structuring the scoring — it applies the Resource Allocation / RICE framework to your candidate list, pressure-testing your Impact and Confidence assumptions and flagging where estimates look optimistic.
  2. Adding financial depth — for capital-heavy candidates (a new service line, an acquisition), it can layer DCF valuation, ratio analysis, and scenario modeling so "Impact" isn't a gut number.
  3. Turning the winner into an execution plan — it produces a board-ready deck and a command-center view with KPIs so the chosen move gets tracked, not shelved.

Percision is a co-pilot, not an autopilot — your clinical and finance leaders own the inputs and the decision. It does not touch PHI-level workflows or replace your revenue-cycle team; it's a strategy layer above operations.

When you don't need it: if you're comparing three straightforward operational fixes and you already have clean denial and no-show data, a one-page spreadsheet and a 60-minute leadership session will do the job. If your decision hinges on payer contract nuance, state regulation, or medical-staff politics, a healthcare-specialist consultant will serve you better than any platform. Use Percision when you have many competing options, real financial stakes, or a board that wants defensible analysis fast — not when the answer is already obvious.

For context on why AI-assisted analysis is gaining traction: a 2023 BCG–Harvard field study found consultants using GPT-4 completed a set of business tasks faster and at higher quality on tasks within the tool's capability — while performing worse on tasks outside it. The lesson for providers: use AI to accelerate structured analysis, keep humans on clinical and contextual judgment.

If you want to run your quarter's candidate list through a structured RICE and financial analysis, you can explore Percision here.

What this looks like when the analysis is actually run

The highest-return move in a provider group is usually defensive, because the profit is concentrated in far fewer places than the revenue is.

The subject is Cedar Ridge Health Partners, a sample company profile we use for testing rather than a customer: a physician-owned multi-specialty group, $196M net patient revenue, 128 physicians, 14 clinics.

Excerpt from a real Percision run · Quick Market Scan (T1) · sample company profile

The concentration nobody had priced. Cedar Ridge's single ambulatory surgery centre currently delivers 34% of the group's operating income on just 11% of its $196M net patient revenue. Two orthopaedic surgeons over age 60 generate roughly 40% of ASC case volume and roughly 70% of ASC EBITDA.

What happens if nothing is done. If either retires without a successor, the group loses roughly $4.8M of annual contribution margin and the entire value-based-care risk-capacity flywheel collapses.

The move. Recruit and retain four mid-career orthopaedic surgeons within 24 months; deploy a lightweight internal referral-optimization platform surfacing real-time ASC capacity and payer-approved procedure lists to the existing 128 physicians; and lock in 6–8% incremental ASC volume.

What it costs and returns. $3.0–4.0M over 24 months — $1.8–2.2M for surgeon succession and retention bonuses, $1.2–1.8M for the referral platform and analytics. Incremental $4.8–6.4M of annual ASC contribution margin by Month 24; payback 14–18 months; lifts group operating margin from 4.2% to 5.8–6.4%. Drawn from the $9M three-year distributable capital already voted by physician-owners.

Go / no-go gates before the next phase is funded
PhaseGate metricTargetDeadline
Foundation (0-6 months)At least two qualified orthopaedic surgeon candidates signed LOIs; referral-leakage baseline documented2 LOIs + baseline reportMonth 6
Traction (6-18 months)ASC case volume +4% YoY; physician turnover ≤10%; platform usage ≥60% of eligible referrals+4% volume, ≤10% turnover, ≥60% usageMonth 18
Scale (18-36 months)ASC contribution ≥40% of group operating income; physician turnover ≤6%; group operating margin ≥5.8%≥40% ASC share, ≤6% turnover, ≥5.8% marginMonth 36

Eleven percent of revenue producing 34% of operating income is the finding, and two surgeons over sixty sit on top of it. That is not a growth problem or a cost problem — it is a single-point-of-failure problem, and it is worth $4.8M a year that nobody had written down as at risk.

Note the margin arithmetic: 4.2% to 5.8–6.4%. On a $196M revenue base a 1.6–2.2 point improvement is the difference between a group that can self-fund its own strategy and one that cannot. In healthcare the highest-ROI move is rarely a new service line; it is protecting the one line that already works.

Read a complete Percision report — every page, no email required.

FAQ

Q: Should we always pick the highest RICE score? No. RICE ranks candidates; it doesn't override strategic necessity. A regulatory compliance fix or safety issue jumps the queue regardless of score. Use RICE to order the discretionary backlog.

Q: What data do we need before scoring? At minimum: denial volumes and reasons, no-show rates by clinic, visit volumes, and rough effort estimates from the teams who'd execute. Confidence scores should drop honestly when this data is thin.

Q: How is this different from a standard ROI calculation? ROI gives you a dollar ratio; RICE adds Reach and Confidence, so a high-ROI-but-tiny-or-uncertain project doesn't beat a slightly-lower-ROI-but-broad-and-certain one. It's built for prioritizing many options under limited staff capacity.

Ready to run this on your company?
A free Percision diagnostic turns the analysis into a decision with owners and numbers — one click from this article.
Run the free diagnostic →
Get the full State of AI Strategy 2026 report
The research, the method, and the pre-registered tests — plus occasional notes on governed AI strategy. No spam; unsubscribe anytime.